A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy
Clinical trial NCT05463744 · COMPLETED
Trial details
- NCT number
- NCT05463744
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-12
- Primary completion
- 2024-05-07
- Enrollment
- 692
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.